4 completed, 1 active not recruiting, 1 terminated. 4 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Terminated 1 |
| Not applicable | 1 | Active not recruiting 1 |
Follow Poliovirus Vaccines: new trials by email Literature Review of Poliovirus Vaccines trials Research Report on Poliovirus Vaccines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers RSVt vaccine, Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine, Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine - RSV Immunization | Phase 3 | Terminated | Sanofi Pasteur, a Sanofi Company | 2226 | 2024-05-13 | 2026-10-05 |
| A Tool Kit to Improve Vaccine Confidence in the Philippines Educational toolkit on MMR and polio vaccination - Measles, Polio | Not applicable | Active not recruiting | University of Toronto | 5400 | 2024-01-31 | 2025-03-11 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV) - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1528 | 2023-03-27 | 2026-01-21 |
| Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine poliovirus vaccine - Poliomyelitis | Phase 3 | Completed | Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control | 600 | 2015-04-01 | 2016-05-30 |
| A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children Poliomyelitis vaccine (inactivated) -PoliorixTM - Poliomyelitis | Completed | GlaxoSmithKline | 349 | 2007-07-01 | 2012-03-19 | |
| Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV Poliomyelitis Vaccine inactivated, Poliomyelitis Vaccine in Dragee Candy (Human Diploid Cell) - Poliomyelitis, Polio | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 600 | 2006-06-01 | 2014-01-22 |
Poliomyelitis (4) · Measles (1) · Vaccination Hesitancy (1)
Sanofi Pasteur, a Sanofi Company (3) · GlaxoSmithKline (1) · Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control (1) · University of Toronto (1)
China (1) · India (1) · Mexico (1) · Philippines (1) · Puerto Rico (1) · South Africa (1) · South Korea (1) · United States (1)
Xiaolin Wei, PhD (1) · Zhaojun Mo (1)